Single‐item discrimination of quality‐of‐life–altering dysphagia among 714 long‐term oropharyngeal cancer survivors: Comparison of patient‐reported outcome measures of swallowing
Authors:
- MD Anderson Head and Neck Cancer Symptom Working GroupMGMD Anderson Head and Neck Cancer Symptom Working Group
- Stephen GrantSGStephen Grant
- Mona KamalMona Kamal
- Abdallah S. R. MohamedAbdallah S. R. Mohamed
- G. Brandon GunnGGG. Brandon Gunn
- Stephen Y. LaiSLStephen Y. Lai
- Jan S. LewinJLJan S. Lewin
- Clifton D. FullerCFClifton D. Fuller
Open Access
- 11 January 2019
- Vol. 125 (10) , 1654-1664
Abstract
Background: Two patient‐reported outcomes (PROs) of swallowing and their correlation to quality of life (QOL) were compared in long‐term survivors of oropharyngeal cancer (OPC). Methods: Scores on the single dysphagia item from the 28‐item, multisymptom MD Anderson Symptom Inventory‐Head and Neck (MDA S I‐HN‐S) were compared with scores on the dysphagia‐specific composite MD Anderson Dysphagia Inventory (MDA D I) and the EuroQol visual analog scale (EQ‐VAS) in 714 patients who had received definitive radiotherapy ≥12 months before the survey. An MDA S I‐HN‐S score ≥6 and an MDA D I composite score S I‐HN‐S and the composite MDA D I, respectively. Both swallow PROs were predictive of QOL, and the MDA S I‐HN‐S model was slightly more parsimonious for the discrimination of EQ‐VAS scores compared with MDA D I scores (Bayesian information criteria, 6062 vs 6076, respectively). An MDA S I‐HN‐S cutoff score of ≥6 correlated best with a declining EQ‐VAS score ( P < .0001) and was associated with increased radiotherapy dose to several normal swallowing structures. Conclusions: In this cohort, the single‐item MDA S I‐HN‐S performed favorably for the discrimination of QOL compared with the multi‐item MDA D I. A time‐efficient model for PRO measurement of swallowing is proposed in which the MDA D I may be reserved for patients who score ≥6 on the MDA S I‐HN‐S.Keywords
Funding Information
- National Institutes of Health (1R01DE025248-01/R56DE025248-01)
- National Institutes of Health (1R01CA218148-01)
- National Institutes of Health (P30CA016672)
- National Science Foundation (NSF 1557679)
- Andrew Sabin Family Foundation
- National Institutes of Health (1R01DE025248-01, R56DE025248-01)
- National Institutes of Health (BD2K)
This publication has 25 references indexed in Scilit:
- Patterns of Disease Recurrence Following Treatment of Oropharyngeal Cancer With Intensity Modulated Radiation TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Does the correspondence between EQ-5D health state description and VAS score vary by medical condition?Health and Quality of Life Outcomes, 2013
- Late dysphagia after radiotherapy‐based treatment of head and neck cancerCancer, 2012
- Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trialThe Lancet Oncology, 2011
- Patient-reported outcomes: A new era in clinical researchPerspectives in Clinical Research, 2011
- Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancerRadiotherapy and Oncology, 2009
- Reliability and validity of the Vanderbilt Head and Neck Symptom Survey: A tool to assess symptom burden in patients treated with chemoradiationHead & Neck, 2009
- The M. D. Anderson Symptom Inventory–Head and Neck Module, a Patient-Reported Outcome Instrument, Accurately Predicts the Severity of Radiation-Induced MucositisInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Impact of Late Treatment-Related Toxicity on Quality of Life Among Patients With Head and Neck Cancer Treated With RadiotherapyJournal of Clinical Oncology, 2008
- Measuring head and neck cancer symptom burden: The development and validation of the M. D. Anderson symptom inventory, head and neck moduleHead & Neck, 2007